Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Alnylam Pharmaceuticals Inc. (ALNY)

ALNY RSS Feed
Add ALNY Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator
Search This Board:
Last Post: 2/11/2014 6:10:05 PM - Followers: 14 - Board type: Free - Posts Today: 0
http://www.alnylam.com/ http://finance.yahoo.com/q/ks?s=ALNY Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing therapeutics based on RNA interference (RNAi). Its development programs include ALN-RSV01, a phase I human clinical trial product for the treatment of respiratory syncytial virus (RSV) infection; ALN-FLU01 for pandemic influenza; and ALN-PCS01 for the treatment of hypercholesterolemia with an RNAi therapeutic. The company also engages in pre-clinical discovery programs for RNAi therapeutics for the treatment of Parkinson's disease, Huntington's disease, neuropathic pain, progressive multifocal leukoencephalopathy, Ebola virus infection, and cystic fibrosis. It has strategic alliances with Merck & Co., Inc.; Medtronic, Inc.; and Novartis and Biogen Idec, Inc. for the development and commercialization of RNA interference system products. Alnylam also has contracts with government agencies, including the National Institute of Allergy and Infectious Diseases. In addition, it has license agreements with biotechnology companies, which engage in developing RNAi therapeutic products; and research companies that commercialize RNAi reagents or services. Further, the company has collaboration agreements with Medtronic, Inc. for the development of drug-device products to treat diseases caused by degeneration of the nervous system; and Biogen Idec, Inc. for research on the use of RNAi technology to discover and develop therapeutics to treat PML. It also has collaboration agreements with Novartis Pharma AG to develop RNAi therapeutics for pandemic flu; University of Texas Southwestern to develop RNAi therapeutics targeting proprotein convertase subtilisn/kexin type 9; and Inex Pharmaceuticals Corporation for the discovery, development, and commercialization of RNAi therapeutics. The company was founded in 2002 and is based in Cambridge, Massachusetts. Gallery View 4: (Full Sto, MACD, Aroon8)
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ALNY
Current Price
Volume:
Bid Ask Day's Range
Wiki
Option Chain for ALNY
ALNY News: Statement of Changes in Beneficial Ownership (4) 09/19/2014 06:20:44 PM
ALNY News: Alnylam to Webcast Presentation at 21st Annual NewsMakers in the Biotech Industry Conference 09/19/2014 04:00:00 PM
ALNY News: Statement of Changes in Beneficial Ownership (4) 09/17/2014 06:25:34 PM
ALNY News: Alnylam Presents New Pre-Clinical Data with ALN-CC5, a Subcutaneously Administered RNAi Therapeutic Targeting Complement Comp... 09/16/2014 08:00:00 AM
ALNY News: Alnylam Strengthens Management Team with New Key Appointments 09/15/2014 08:00:00 AM
News News Alert: Statement of Changes in Beneficial Ownership (4) 09/19/2014 06:20:44 PM
PostSubject
#155   New nanoparticles offer best-ever gene silencing, Wildbilly 02/11/14 06:10:05 PM
#154   RSI oversold here IMO sharky 02/06/14 10:29:42 AM
#153   Wow! Biotech investing can be so exhilarating! One Flap 01/13/14 10:29:57 AM
#152   8:00AM Alnylam Pharma presents new pre-clinical data on surf1944 12/19/13 11:20:34 AM
#151   8:07AM Alnylam Pharma initiates phase ii clinical trial surf1944 12/16/13 11:46:54 AM
#150   This is going to triple digits pete7 12/06/13 12:55:52 PM
#149   Very good article about RNAi therapeutics changing the Inoviorulez 11/05/13 05:18:02 PM
#148   7:02AM Alnylam Pharma reports positive clinical results -- surf1944 09/23/13 10:11:20 AM
#147   Looking good soon this will fly pete7 08/29/13 01:05:25 PM
#146   Interest points discussed at JMP Securities 2013 Healthcare Conference.... Nickw 07/23/13 09:07:41 AM
#145   8:01AM Alnylam Pharma presents key pre-clinical proof-of-concept data surf1944 05/17/13 11:39:23 AM
#144   Alnylam Pharmaceuticals' CEO Discusses Q4 2012 Results - surf1944 02/08/13 10:59:42 AM
#143   Will RGLS have any affect from ALNY shooting Gimmysomeofdat22 01/28/13 10:41:00 AM
#142   8:01AM Alnylam Pharma presents new pre-clinical data on surf1944 11/14/12 09:06:18 AM
#140   8:02AM Alnylam Pharma and collaborators publish new pre-clinical surf1944 08/22/12 09:18:26 AM
#139   I was a little early. Tim Lento 07/17/12 08:52:19 AM
#138   8:02AM Alnylam Pharma and Ascletis form strategic collaboration surf1944 07/12/12 09:50:02 AM
#137   ALNY Alnylam Receives Orphan Drug Designation from U.S. Pyckstocks 06/19/12 09:14:22 AM
#136   8:03AM Alnylam Pharma collaborators publish new pre-clinical results surf1944 06/12/12 10:09:05 AM
#135   8:02AM Alnylam initiates Phase II clinical trial of surf1944 06/07/12 09:05:48 AM
#134   Alnylam Pharma announces top-line results of Phase IIb mlkrborn 05/30/12 09:26:29 AM
#133   7:02AM Alnylam Pharma presents final results from a surf1944 05/10/12 08:25:33 PM
#132   Not even mentioned in the PR by ALNY urche 04/20/12 11:36:00 AM
#131   Alnylam Reports Positive Clinical Results for ALN-PCS, an surf1944 04/20/12 08:35:01 AM
#130   Future Trends In RNAi Drug Delivery surf1944 04/01/12 10:59:50 PM
#129   stox sale @10.75 mlkrborn 02/15/12 04:22:33 AM
#128   ~ $ALNY ~ Earnings posted, pending or coming Fa$tlane 02/06/12 04:14:20 AM
#127   http://www.insidercow.com/history/company.jsp?company=alny&B1=Search! surf1944 01/05/12 09:15:01 AM
#126   Regulus Therapeutics to Present microRNA Platform and Pipeline surf1944 01/05/12 09:14:04 AM
#125   January 5, 2012 surf1944 01/05/12 09:13:15 AM
#124   Thanks for posting your notes. That was helpful. urche 11/27/11 11:22:17 AM
#123   Notes from conference call related to ALN-TTR phase acgood 11/25/11 04:14:42 PM
#122   Alnylam Pharma grants InterfeRx intellectual property license to mlkrborn 11/16/11 06:08:04 PM
#121   Alnylam Pharma ALNY Rodman & Renshaw Mkt Outperform $12 surf1944 10/14/11 09:55:18 AM
#120   http://investorshub.advfn.com/boards/read_msg.aspx?message_id=67906528 hptaxis 10/12/11 08:47:14 AM
#119   Good work---and thanks in advance for the UBS urche 10/02/11 05:50:49 PM
#118   ALNY notes from Rodman and Renshaw conference: acgood 10/02/11 01:29:07 PM
#117   8:45AM On The Wires (WIRES) : surf1944 09/26/11 09:14:16 AM
#116   Alnylam to Webcast Presentation at the JMP Securities KarinCA 09/22/11 11:03:39 AM
#115   No problem. acgood 09/16/11 01:34:41 PM
#114   Thank you,acgood, for sharing blog and notes. urche 09/16/11 12:38:37 PM
#113   Notes from various ALNY conference calls and webcasts: acgood 09/14/11 10:02:17 AM
#112   MGM, Monsanto among Tuesday upgrades surf1944 09/13/11 12:16:13 PM
#111   Alnylam Scientists & Collaborators Report Significant New Advances KarinCA 09/12/11 10:56:26 AM
#110   Alnylam Pharma completes ALN-VSP Phase I trial in mlkrborn 08/01/11 11:49:25 AM
#109   Alnylam and MIT Collaborators Discover Novel “Core-Shell” Nanoparticles KarinCA 07/25/11 01:19:46 PM
#108   ALNY - Alnylam and MIT Collaborators Publish Data KarinCA 07/20/11 02:09:14 AM
#107   Alnylam Files Clinical Trial Application (CTA) for ALN-PCS, KarinCA 07/11/11 12:19:57 PM
#106   ALNY - Alnylam Files Answer and Counterclaim Related KarinCA 06/29/11 02:33:13 PM
#105   8:05AM Alnylam Pharma presents new data from ALN-TTR surf1944 06/28/11 09:29:56 AM
PostSubject